Table 2.
Details of the Patients for Whom Treatment Failed
| Patient | Age (years) | Histology | Disease Site | Tumor Size (cm) | Group | RT Dose (GyRBE) | Failure Type | Time to Failure (months) | Status at Analysis |
|---|---|---|---|---|---|---|---|---|---|
| 01 | 6 | Emb | PM-ICE | > 5 | IIIa | 50.4 | Local | 7 | Deceased |
| 18 | 2 | Emb | PM-ICE | > 5 | IIIb | 50.4 | Local | 13 | Deceased |
| 39 | 10 | Emb | PM-ICE | > 5 | IIIa | 50.4 | Local | 17 | Alive |
| 02 | 2 | Emb | PM | ≤ 5 | IIIa | 50.4 | Local | 8 | Deceased |
| 29 | 16 | Emb | PM | > 5 | IIIa | 50.4 | Local | 12 | Deceased |
| 38 | 2 | Alv | Head and neck | ≤ 5 | IIIb | 50.4 | Local | 10 | Deceased |
| 16 | 1 | Alv | Head and neck | ≤ 5 | IIc | 41.4 | Local | 24 | Alive |
| 07 | 15 | Emb | Orbit | ≤ 5 | IIIb | 45 | Local | 6 | Alive |
| 17 | 1 | Emb | Prostate | > 5 | IIIa* | 37.8 | Regional | 7 | Deceased |
| 40 | 11 | Emb | PM | ≤ 5 | IIIa | 50.4 | Regional | 15 | Alive |
| 27 | 9 | Emb | PM-ICE | > 5 | IIIa | 50.4 | Regional | 48 | Alive |
| 41 | 8 | Emb | PM-ICE | ≤ 5 | IIIa | 50.4 | Distant | 3 | Deceased |
| 15 | 8 | Emb | PM | ≤ 5 | IIIa | 50.4 | Distant | 9 | Deceased |
| 35 | 2 | Emb | Extremity | > 5 | IIc | 41.4 | Distant | 4 | Deceased |
| 12 | 7 | Emb | PM | > 5 | IIIa | 50.4 | Local and distant | 3 | Deceased |
| 08 | 1 | Alv | Perineal | ≤ 5 | IIIa | 50.4 | Local, regional, and distant | 3 | Deceased |
Abbreviations: Alv, alveolar; Emb, embryonal; PM, parameningeal; PM-ICE, parameningeal with intracranial extension; RBE, relative biologic effectiveness; RT, radiotherapy.
*
Patient was Group IIIa at treatment initiation but underwent delayed primary resection.